Influenza Vaccine

The influenza vaccine drug class consists of immunizing biological agents formulated as inactivated, recombinant, or live-attenuated viral preparations These vaccines stimulate active immunity by inducing the host immune system to produce neutralizing antibodies primarily targeted against the influenza hemagglutinin surface glycoprotein

These vaccines stimulate active immunity by inducing the host immune system to produce neutralizing antibodies primarily targeted against the influenza hemagglutinin surface glycoprotein

Their primary therapeutic role is the active immunization and prevention of respiratory illness and associated severe complications caused by circulating influenza A and B viruses

Their primary therapeutic role is the active immunization and prevention of respiratory illness and associated severe complications caused by circulating influenza A and B viruses

Formulations are updated seasonally to align with circulating viral strains and are widely indicated for routine annual prophylaxis across pediatric, adult, and high-risk populations

Formulations are updated seasonally to align with circulating viral strains and are widely indicated for routine annual prophylaxis across pediatric, adult, and high-risk populations